Disclaimer: IPO details, GMP, subscription figures, and other related information are for informational purposes only and may not always be accurate or up to date. Please verify the latest details from official sources before investing.
Paras Healthcare Limited is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through eight hospitals across North India, Bihar and Jharkhand.
The hospitals operate under the Paras Health brand and had an aggregate bed capacity of 2,211 beds as of June 30, 2026. Its clinical focus includes cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences, alongside other multi-specialty services.
Revenue is generated primarily from healthcare services provided to in-patients and out-patients, sale of pharmacy products and other operating revenues. The network serves patients across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar, and is supported by doctors, nurses, clinical infrastructure and digital hospital systems. The company is also expanding its network through planned hospitals in Gurugram and Ludhiana.
| Category | Shares Offered | Shares Applied | Subscription Times (x) |
|---|
| Category | Shares Offered | Shares Applied | Subscription Times (x) |
|---|
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Profit* | Last Updated |
|---|---|---|---|---|---|
| 17-10-2026 | ₹693 | ₹95 | ₹788 ( 13.71% ) | ₹1,995.00 | 17-Oct-2026 10:01 AM |
| 16-10-2026 | ₹693 | ₹95 | ₹788 ( 13.71% ) | ₹1,995.00 | 16-Oct-2026 10:07 AM |
| 15-10-2026 | ₹693 | ₹776 | ₹1469 ( 111.98% ) | ₹16,296.00 | 15-Oct-2026 11:30 AM |
A quick overview of the key Financial Performance of Paras Healthcare Limited.
*All values are in Rs. Cr
Revenue decreased by 71%, Profit after Tax (PAT) increased by 13%, Total Assets increased by 6% between FY2026 and FY2027 (Jun).
| Period Ended | FY2024 | FY2025 | FY2026 (Jun) | FY2026 | FY2027 (Jun) |
|---|---|---|---|---|---|
| Revenue | 1,129.04 | 1,294.06 | 368.39 | 1,605.95 | 470.28 |
| Assets | 1,477.66 | 1,810.45 | 1,925.74 | 2,071.14 | 2,202.88 |
| Total Income | 1,151.02 | 1,314.21 | 374.23 | 1,628.78 | 478.75 |
| Profit After Tax | -15.33 | -57.98 | -1.02 | 43.83 | 49.68 |
| EBITDA | 154.41 | 156.46 | 66.31 | 335.58 | 113.48 |
| Net Worth | 338.51 | 280.49 | 348.68 | 394.94 | 444.96 |
| Reserves & Surplus | 328.75 | 270.73 | 338.58 | 384.84 | 434.86 |
| Total Borrowings | 547.53 | 727.93 | 750.01 | 854.10 | 888.89 |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 21 | ₹ 14,553 |
| Retail (Max) | 13 | 273 | ₹ 1,89,189 |
| S-HNI (Min) | 14 | 294 | ₹ 2,03,742 |
| S-HNI (Max) | 68 | 1,428 | ₹ 9,89,604 |
| B-HNI (Min) | 69 | 1,449 | ₹ 10,04,157 |
| KPI | Latest |
|---|---|
| ROE (%) | 11.83 |
| ROCE (%) | 4.23 |
| Debt / Equity | 3.21 |
| RoNW (%) | 11.83 |
| PAT Margin (%) | 10.38 |
| EBITDA Margin (%) | 23.7 |
|
Pre IPO
Post IPO
|
|
| EPS (₹) |
4.92
-
|
| P/E (x) |
-
-
|
| Promoter Holding (%) |
72.8
-
|
